X Trademark

Trademark Overview


On Monday, August 8, 2022, a trademark application was filed for X with the United States Patent and Trademark Office. The USPTO has given the X trademark a serial number of 97539827. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, December 10, 2024. This trademark is owned by Elsie Biotechnologies Inc.. The X trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of oligonucleotides

Oligonucleotide compounds for use as pharmaceutical therapies for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses ; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals

Oligonucleotide compounds for use in the manufacture of pharmaceutical therapies

Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds
x

General Information


Serial Number97539827
Word MarkX
Filing DateMonday, August 8, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements


Goods and ServicesCustom manufacture of oligonucleotides
Description of MarkThe mark consists of a series of short horizontal lines formed into the shape of an "X", superimposed on and largely within a diamond shape with rounded corners.
Goods and ServicesOligonucleotide compounds for use as pharmaceutical therapies for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses ; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesOligonucleotide compounds for use in the manufacture of pharmaceutical therapies
Goods and ServicesResearch and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, August 2, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElsie Biotechnologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameElsie Biotechnologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, August 11, 2022NEW APPLICATION ENTERED
Monday, August 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 24, 2023ASSIGNED TO EXAMINER
Friday, June 16, 2023NON-FINAL ACTION WRITTEN
Friday, June 16, 2023NON-FINAL ACTION E-MAILED
Friday, June 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024SOU EXTENSION 1 FILED
Tuesday, April 30, 2024SOU EXTENSION 1 GRANTED
Wednesday, May 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024SOU EXTENSION 2 FILED
Tuesday, November 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 11, 2024SOU EXTENSION 2 GRANTED